Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. The update does not alter the study content, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a small editorial update. This change reflects metadata updates rather than modifications to the study details or results.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.6.3 appears on the study page, replacing the previous v3.6.2, indicating a version update of the ClinicalTrials.gov record.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page displays a newer revision tag (v3.6.2) replacing the previous v3.6.0. This reflects a minor backend or template update rather than substantive changes to the study information.SummaryDifference0.0%

- Check58 days agoChange DetectedThe enrollment status now shows that the study is no longer looking for participants. The page adds guidance sections to help readers understand and participate, and the revision note updates to v3.6.0 with a formatting adjustment for the Intervention/Treatment heading.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small platform update rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.